Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Sartiano

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Oncology|January 1, 1975
Primary reticulum cell sarcoma of the uterusJ A Gall, G Sartiano, M Deutsch
Cancer|July 1, 1976
Observations following Corynebacterium parvum administration to patients with advanced malignancy. a phase I studyB Fisher, H Rubin, G Sartiano, et al.
Cancer|September 15, 1990
Ondansetron for the prevention of emesis induced by high-dose cisplatin. A multi-center dose-response studyA Khojasteh, G Sartiano, E Tapazoglou, et al.
The American Journal of Medicine|August 1, 1988
Recombinant interferon alpha-2a for treatment of herpes zoster in immunosuppressed patients with cancerD J Winston, L J Eron, M Ho, et al.
Cancer|June 15, 1981
Combination chemotherapy with and without the methanol-extracted residue of bacillus Calmette-Guerin (MER) in extensive non-small-cell lung cancer: a prospective randomized study for the Piedmont Oncology AssociationF Richards, V Howard, A Shore, et al.
Cancer|July 1, 1982
Combination chemotherapy-radiotherapy with and without the methanol-extraction residue of Bacillus Calmette-Guerin (MER) in small cell carcinoma of the lung: a prospective randomized trial of the Piedmont Oncology AssociationD V Jackson, B R Paschal, C Ferree, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Oncology|January 1, 1975
Primary reticulum cell sarcoma of the uterusJ A Gall, G Sartiano, M Deutsch
Cancer|July 1, 1976
Observations following Corynebacterium parvum administration to patients with advanced malignancy. a phase I studyB Fisher, H Rubin, G Sartiano, et al.
Cancer|September 15, 1990
Ondansetron for the prevention of emesis induced by high-dose cisplatin. A multi-center dose-response studyA Khojasteh, G Sartiano, E Tapazoglou, et al.
The American Journal of Medicine|August 1, 1988
Recombinant interferon alpha-2a for treatment of herpes zoster in immunosuppressed patients with cancerD J Winston, L J Eron, M Ho, et al.
Cancer|June 15, 1981
Combination chemotherapy with and without the methanol-extracted residue of bacillus Calmette-Guerin (MER) in extensive non-small-cell lung cancer: a prospective randomized study for the Piedmont Oncology AssociationF Richards, V Howard, A Shore, et al.
Cancer|July 1, 1982
Combination chemotherapy-radiotherapy with and without the methanol-extraction residue of Bacillus Calmette-Guerin (MER) in small cell carcinoma of the lung: a prospective randomized trial of the Piedmont Oncology AssociationD V Jackson, B R Paschal, C Ferree, et al.
Pageof 1